Influencing factors on instrumental activities of daily living functioning in people with mild cognitive disorder - a secondary investigation of cross-sectional data.
Cognitive function
Instrumental activities of daily living
Mild neurocognitive disorder
Personal and environmental factors
Physical function
Journal
BMC geriatrics
ISSN: 1471-2318
Titre abrégé: BMC Geriatr
Pays: England
ID NLM: 100968548
Informations de publication
Date de publication:
11 10 2022
11 10 2022
Historique:
received:
08
06
2022
accepted:
23
09
2022
entrez:
10
10
2022
pubmed:
11
10
2022
medline:
13
10
2022
Statut:
epublish
Résumé
Finding a strategy to reduce the impact of cognitive decline on everyday functioning in persons suffering from cognitive impairment is a public health priority. Instrumental activities of daily living (IADL) are key to everyday functioning. Hence, it is essential to understand the influencing factors on IADL to develop specific interventions to improve everyday functioning in persons with mild cognitive disorder. Therefore, this study aimed to 1) explore different influencing factors on IADL functioning considering all domains of the International Classification of Functioning, disability, and health and 2) rank these factors. We performed a secondary analysis of a cohort including participants with amnestic mild cognitive impairment (a-MCI) or mild Alzheimer's Dementia (mild AD). The IADL functioning model was used as a starting point to estimate the effects of cognitive and physical function factors and personal and environmental factors on IADL functioning using multiple linear regression analysis, including subgroup analysis in persons with a-MCI. We used standardized coefficient estimates to relate the size of the predictor effects in the final model. We included 105 participants (64 a-MCI, 41 mild AD); the mean age was 81.9 years (SD 4.9), with 70% females. Based on a multi-step approach and model fit, the final model included IADL functioning as the response variable and memory, attention, executive function, vision and hearing, mobility, balance, education, and social support as predictors. The final model explained 75% of the variability. The significant predictors in the model were mobility, balance, attention, and education, and were the predictors with the most considerable effects based on standardized coefficient estimates. The subgroup analysis, including only a-MCI participants, revealed a similar pattern. Our results confirm that IADL functioning in people with mild cognitive disorder is influenced by cognitive and physical function and personal factors. The study provides further insight into understanding IADL functioning impairments in persons with mild impaired cognition and may be used to develop specific non-pharmacological interventions.
Sections du résumé
BACKGROUND
Finding a strategy to reduce the impact of cognitive decline on everyday functioning in persons suffering from cognitive impairment is a public health priority. Instrumental activities of daily living (IADL) are key to everyday functioning. Hence, it is essential to understand the influencing factors on IADL to develop specific interventions to improve everyday functioning in persons with mild cognitive disorder. Therefore, this study aimed to 1) explore different influencing factors on IADL functioning considering all domains of the International Classification of Functioning, disability, and health and 2) rank these factors.
METHODS
We performed a secondary analysis of a cohort including participants with amnestic mild cognitive impairment (a-MCI) or mild Alzheimer's Dementia (mild AD). The IADL functioning model was used as a starting point to estimate the effects of cognitive and physical function factors and personal and environmental factors on IADL functioning using multiple linear regression analysis, including subgroup analysis in persons with a-MCI. We used standardized coefficient estimates to relate the size of the predictor effects in the final model.
RESULTS
We included 105 participants (64 a-MCI, 41 mild AD); the mean age was 81.9 years (SD 4.9), with 70% females. Based on a multi-step approach and model fit, the final model included IADL functioning as the response variable and memory, attention, executive function, vision and hearing, mobility, balance, education, and social support as predictors. The final model explained 75% of the variability. The significant predictors in the model were mobility, balance, attention, and education, and were the predictors with the most considerable effects based on standardized coefficient estimates. The subgroup analysis, including only a-MCI participants, revealed a similar pattern.
CONCLUSION
Our results confirm that IADL functioning in people with mild cognitive disorder is influenced by cognitive and physical function and personal factors. The study provides further insight into understanding IADL functioning impairments in persons with mild impaired cognition and may be used to develop specific non-pharmacological interventions.
Identifiants
pubmed: 36217106
doi: 10.1186/s12877-022-03476-8
pii: 10.1186/s12877-022-03476-8
pmc: PMC9552428
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
791Informations de copyright
© 2022. The Author(s).
Références
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Alzheimers Res Ther. 2015 Mar 18;7(1):17
pubmed: 25815063
Int Psychogeriatr. 2012 Jun;24(6):948-58
pubmed: 22278151
J Gerontol. 1982 Jan;37(1):91-9
pubmed: 7053405
Psychol Med. 2013 Nov;43(11):2437-45
pubmed: 23308393
J Clin Psychol. 1987 Jul;43(4):402-9
pubmed: 3611374
Acta Neurol Scand Suppl. 2003;179:42-6
pubmed: 12603250
Neurology. 1984 Jul;34(7):939-44
pubmed: 6610841
J Adv Nurs. 2000 Oct;32(4):1008-15
pubmed: 11095242
Int Psychogeriatr. 2018 Dec;30(12):1837-1848
pubmed: 29564999
Age (Dordr). 2016 Dec;38(5-6):525-533
pubmed: 27566307
J Neuropsychiatry Clin Neurosci. 2007 Summer;19(3):249-65
pubmed: 17827410
Gerontology. 2017;63(1):67-83
pubmed: 27172932
J Am Geriatr Soc. 2005 Jul;53(7):1197-202
pubmed: 16108938
Int J Geriatr Psychiatry. 2011 Aug;26(8):843-52
pubmed: 20845500
BMC Neurol. 2020 Jul 1;20(1):264
pubmed: 32611388
Front Med (Lausanne). 2017 Dec 18;4:230
pubmed: 29326936
Clin Neuropsychol. 2014;28(5):726-46
pubmed: 24766574
Arch Gerontol Geriatr. 2011 Mar-Apr;52(2):e67-70
pubmed: 20678819
Int J Geriatr Psychiatry. 2008 May;23(5):523-30
pubmed: 18058828
J Rehabil Med. 2005 Jul;37(4):212-8
pubmed: 16024476
J Am Osteopath Assoc. 2019 Feb 01;119(2):96-101
pubmed: 30688355
Arch Gerontol Geriatr. 2000 Jan-Feb;30(1):17-24
pubmed: 15374045
Clin Neuropsychol. 1999 Nov;13(4):450-5
pubmed: 10806458
J Neuropsychiatry Clin Neurosci. 2012 Winter;24(1):37-46
pubmed: 22450612
J Neurol Sci. 2011 Jun 15;305(1-2):121-5
pubmed: 21420690
J Intern Med. 2004 Sep;256(3):183-94
pubmed: 15324362
JAMA. 1963 Sep 21;185:914-9
pubmed: 14044222
PLoS One. 2014 Jun 09;9(6):e99318
pubmed: 24911155
J Am Geriatr Soc. 2008 Jul;56(7):1244-51
pubmed: 18482293
Annu Rev Psychol. 2013;64:135-68
pubmed: 23020641
Int Psychogeriatr. 2016 Feb;28(2):247-59
pubmed: 26307191
Gerontologist. 1969 Autumn;9(3):179-86
pubmed: 5349366
J Nutr Health Aging. 2013 Jan;17(1):64-71
pubmed: 23299382
Neurol Sci. 2021 May;42(5):1773-1783
pubmed: 33738665
J Cachexia Sarcopenia Muscle. 2020 Feb;11(1):3-25
pubmed: 31788969
Aging Ment Health. 2015;19(10):859-75
pubmed: 25632849
Harv Rev Psychiatry. 2015 Sep-Oct;23(5):320-8
pubmed: 26332215
Arch Phys Med Rehabil. 2019 Mar;100(3):509-513
pubmed: 30092204
Int Psychogeriatr. 2015 Sep;27(9):1419-27
pubmed: 25901578
Neurology. 2000 Dec 12;55(11):1621-6
pubmed: 11113214
Neurodegener Dis Manag. 2012 Oct 1;2(5):483-491
pubmed: 23585777
Aging Ment Health. 2015 Jan;19(1):2-12
pubmed: 24914889
Int J Geriatr Psychiatry. 2019 Jun;34(6):889-899
pubmed: 30761619
Prev Vet Med. 1997 Jan;29(3):221-39
pubmed: 9234406
Top Cogn Sci. 2022 Apr;14(2):295-310
pubmed: 34128585
J Clin Exp Neuropsychol. 2012;34(1):11-34
pubmed: 22053873
Psychopharmacol Bull. 1983;19(3):448-50
pubmed: 6635122
J Intern Med. 2014 Mar;275(3):214-28
pubmed: 24605806
Neurobiol Aging. 2017 Dec;60:164-172
pubmed: 28968586
Int J Environ Res Public Health. 2021 Nov 05;18(21):
pubmed: 34770137
Neuropsychology. 2021 Jan;35(1):3-18
pubmed: 33393796
Neuropsychol Rev. 2016 Jun;26(2):129-59
pubmed: 27393566
J Am Geriatr Soc. 2002 Sep;50(9):1525-34
pubmed: 12383150
Aging Clin Exp Res. 2018 Nov;30(11):1297-1306
pubmed: 30078097
Lancet. 2020 Aug 8;396(10248):413-446
pubmed: 32738937
J Am Geriatr Soc. 1990 Oct;38(10):1105-12
pubmed: 2229864
Child Neuropsychol. 2003 Sep;9(3):221-33
pubmed: 13680411
J Psychosom Res. 2010 Nov;69(5):511-20
pubmed: 20955871
Arch Clin Neuropsychol. 2016 Mar;31(2):123-47
pubmed: 26743326
Neurodegener Dis Manag. 2014;4(5):393-400
pubmed: 25405652
PLoS One. 2018 Feb 15;13(2):e0192971
pubmed: 29447253
Neurol Sci. 2022 Apr;43(4):2481-2490
pubmed: 34773209
BMJ. 2021 Sep 30;374:n2061
pubmed: 34593508
PLoS Med. 2017 Mar 14;14(3):e1002250
pubmed: 28291801
Ageing Res Rev. 2015 Nov;24(Pt B):304-27
pubmed: 26462882
Proc Nutr Soc. 2014 May;73(2):237-48
pubmed: 24456831
Int J Geriatr Psychiatry. 2010 Dec;25(12):1280-7
pubmed: 21086538
Int Psychogeriatr. 2008 Dec;20(6):1104-15
pubmed: 18752698
Alzheimers Res Ther. 2017 Apr 17;9(1):27
pubmed: 28412978
J Gerontol A Biol Sci Med Sci. 2006 Jul;61(7):726-35
pubmed: 16870636
J Am Geriatr Soc. 1986 Feb;34(2):119-26
pubmed: 3944402
J Nutr Health Aging. 2013 Mar;17(3):235-9
pubmed: 23459976
J Gerontol A Biol Sci Med Sci. 2014 Nov;69(11):1415-21
pubmed: 25182601
Lancet Neurol. 2016 Apr;15(5):455-532
pubmed: 26987701
Front Public Health. 2021 Feb 15;8:516151
pubmed: 33659228
Int J Geriatr Psychiatry. 2021 Feb;36(2):314-323
pubmed: 32892375
J Am Geriatr Soc. 2015 Mar;63(3):590-3
pubmed: 25800907
Int J Geriatr Psychiatry. 2001 Nov;16(11):1092-7
pubmed: 11746656